Tranexamic acid for trauma bleeding with blood clot monitoring
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have a serious injury (injury severity score between 16 and 50)
- You have low blood pressure or a fast heart rate from bleeding
- You can get the study drug within 3 hours of injury
- You do not have a clotting disorder or autoimmune disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
Hear when a new Trauma Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.